Oncology Days | Day 5 |Prostate Cancer
Prostate cancer is the second most common type of cancer in men. For all men with elevated PSA and clinical suspicion of prostate cancer, MRI has transformed the diagnostic pathway with a frontline position before prostate biopsies. The superior sensitivity of MRI also complements the ultrasound-guided biopsy in an innovative fusion technique to target a suspicious lesion and shortening your procedure time. Our speakers will share all the newest developments in the exciting field of prostate cancer together with the benefits of our technology in this field.
Speaker
Prof. Jelle Barentsz
Professor of Radiology, Chair Prostate
Radboud University Medical Center Nijmegen, the Netherlands
Dr. Pierre Leyendecker
Radiologist
Medical Imaging Group – MIM, Sainte Anne Clinic Strasbourg, France
Prof. Richard G. Barr
Radiologist
Northeastern Ohio Medical University Ohio, United States of America
Dr. Katrien Gieraerts
Radiologist
AZ Sint-Jan Brugge AV, Bruges, BelgiumCourse Information
At the end of this video, viewers will be able to:
- Understand the importance of multi-parametric MRI interpretation for the practicing radiologist
- How multi-parametric MRI is used in for the clinical management of prostate cancer patients
- Technical novelties of prostate MRI in 2022
- How MRI-TRUS fusion-guided transperineal prostate biopsy increases the cancer detection rate
This educational talk was created in April 2022. All information contained in this session was correct at the time of distribution.
Disclaimer: Appearing on the Canon Medical Academy does not represent a commercial partnership or interest from the speaker. The views herein do not represent the views of Canon Medical Systems Ltd.
